BioCentury
ARTICLE | Clinical News

Aviron starts EBV Phase II

October 25, 2000 7:00 AM UTC

AVIR began Phase II testing of its Epstein- Barr virus (EBV) vaccine in 81 patients in Belgium. The product is an EBV surface antigen combined with partner SmithKline Beecham Biologicals' adjuvant. Th...